A Phase I in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 176 in Subjects with Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Hackensack

Sponsor
Amgen

Protocol Number
20150161

To Learn More Call
201-510-0910